Preparation, characterization, in vitro and in vivo evaluation of transdermal matrix films of celecoxib

Acta Pharmaceutica Sciencia

Volumn 53, Issue 1, 2011, Pages 67-76

  Sharma, Ramkrishan ^a   Mehra, Gilhotra Ritu ^a  

^a SURESH GYAN VIHAR UNIVERSITY   (India)

Author keywords

Celecoxib; In vitro drug release; In vivo study; Matrix system; Transdermal drug delivery

Indexed keywords

2 PROPANOL; CELECOXIB; EUCALYPTUS OIL; GLYCEROL; HYDROXYPROPYLMETHYLCELLULOSE; PENETRATION ENHANCING AGENT; PHOSPHATE BUFFERED SALINE; PLASTICIZER; POLYVINYL ALCOHOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTHRITIS; ARTICLE; CONTROLLED STUDY; DISEASE MODEL; DRUG CONTENT PER PATCH; DRUG DETERMINATION; DRUG DOSAGE FORM COMPARISON; DRUG FORMULATION; DRUG PENETRATION; DRUG RELEASE; FILM; FILM FLATNESS; FILM SURFACE PH; FILM THICKNESS; FIRST ORDER KINETICS; FOLDING ENDURANCE; HIGUCHI KINETICS; IN VITRO STUDY; MALE; MATHEMATICAL MODEL; MATRIX TYPE TRANSDERMAL PATCH; MOISTURE; MOISTURE UPTAKE; NONHUMAN; PAW EDEMA; PH; PHYSICAL PARAMETERS; RAT; SKIN PENETRATION; TENSILE STRENGTH; TRANSDERMAL PATCH; TRANSPORT KINETICS; WATER TRANSPORT; WEIGHT UNIFORMITY; ZERO ORDER KINETICS;

EID: 79958153807     PISSN: 13072080     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Aqil, M., Sultana, Y. and Ali, A. (2003). Matrix type transdermal drug delivery systems of metoprolol tartrate: In vivo characterization. Acta Pharm. 53: 119-125.
2. Baboota, S., Shakeel, F., Ahuja, A., Ali, J. and Shafiq, S. (2007). Design, development and evaluation of novel nanoemulsion formulation for transdermal potential of celecoxib. Acta Pharm. 57: 315-332.
3. Bhatt, D.C., Dhake, A.S., Khar, R.K. and Mishra, D.N. (2008). Development and in-vitro evaluation of transdermal matrix films of metoprolol tartrate. Yakugaku Zasshi 128: 1325-31.
4. Brown, M.B., Martin, G.P., Jones, S.A. and Akomeah, F.K. (2006). Dermal and transdermal drug delivery systems: current and future prospects. Drug Deliv. 13: 175-187.
5. Chandak, A.R. and Verma, P.R. (2008). Design and development of hydroxypropyl methyl cellulose (HPMC) based polymeric films of methotrexate. Yakugaku Zasshi 128: 1057-1066.
6. Chandra, A. and Kumar, S.P. (2009). Transdermal delivery of ketorolac. Yakugaku Zasshi 129: 373-379.
7. Gattani, S.G., Gaud, R.S. and Chaturvedi, S.C. (2007). Formulation and evaluation of transdermal films of Chlorpheniramine maleate. Indian Drugs 1: 27-33.
8. Gaurel, A.M. and Martel, J.C. (1997). Celecoxib, anti-inflammatory, cyclo-oxygenase-2 inhibitor. Drug Future 22: 711-714.
9. Hadgraft, J. and Lane, M.E. (2008). Effect of enhancers on permeation kinetics of captopril for transdermal system. Int. J. Pharm. 2: 35-37.
10. Jamakandi, V.G., Mulla, J.S., Vinay, B.L., and Shivakumar, H.N., (2009). Formulation, characterization and evaluation of matrix-type transdermal patches of a model antihypertensive drug. Asian J. Pharm. 3: 59-65.
11. Kesavanarayanan, K.S., Nappinnai, M., and Ilavarasan, R. (2007). Topical dosage form of valdecoxib: Preparation and pharmacological evaluation. Acta Pharm. 57: 199-209.
12. Li, T., Ren, C., Wang, M., and Zhao, L. (2007). Optimized preparation and evaluation of indomethacin transdermal patch. Asian J. Pharm. Sci. 2: 249-259.
13. Prausnitz, M.R., Mitragotri, S. and Langer, R. (2004). Current status and future potential of transdermal drug delivery. Drug Discov. 3: 115-124.
14. Tanwar, Y.S., Chauhan, C.S. and Sharam, A. (2007). Development and evaluation of carvedilol transdermal patches. Acta pharm. 57: 151-159.